Benefits, Harms and Alternatives

#Compare options against the same goals

A useful comparison begins with the problem a treatment is intended to address. Possible benefits include longer life, fewer complications, symptom relief or better function. These outcomes are not interchangeable. Improving a laboratory result may be helpful, but it does not always establish an improvement in everyday health.

For each option, important questions include how much benefit is expected, how soon it might appear and how long it may last. Evidence may be strong for one outcome and limited for another. Average study results also leave uncertainty about what will happen to any one person.

#Make benefits and harms understandable

Harms can range from temporary discomfort to serious or lasting complications. Their likelihood, severity, duration and reversibility all matter. Treatment may also involve monitoring, recovery time or disruption to daily life. A rare severe harm and a common mild harm present different kinds of trade-offs.

Numerical information is easier to compare when it uses the same time period and denominator, such as events among every 100 people over one year. Absolute differences show how many more or fewer events occur. Relative changes alone can make an effect seem larger without revealing the starting risk.

#Include reasonable alternatives

Alternatives may include another medicine, a procedure, rehabilitation or a combination of approaches. In some situations, observation or no active treatment is also reasonable. Observation can involve planned reassessment rather than doing nothing. Delaying treatment may carry risks, and its suitability depends on the condition.

A balanced discussion separates what is known from what remains uncertain and considers how each option fits the person's priorities. It also explains what might lead to a later change. The purpose is not to find a universally best choice, but to understand the trade-offs among clinically appropriate options.

#Common misunderstandings

A treatment that helps some people will not help everyone, and a larger effect on a test result does not always mean a noticeable improvement in daily life. Benefits may also take time to appear or may not last.

“Lower risk” can sound more impressive than it is. A relative reduction describes a change compared with the starting risk; the absolute reduction shows how much that risk actually changes. Both need a clear timeframe.

A harm described as “common” is not necessarily serious, while a rare harm can still matter greatly. Severity, duration and whether a harm can be reversed are important alongside its likelihood.

“No treatment” does not always mean no care: monitoring, symptom support or planned review may still be available. Equally, waiting is not automatically harmless. Uncertainty does not prove that options are equivalent; it means the evidence cannot confidently establish their benefits or harms.

#Questions worth asking a clinician

• What benefits could I realistically expect from each option, and how likely are they to improve my daily life?
• What harms could each option cause, how likely are they, and could any be serious or lasting?
• What are my reasonable alternatives, including waiting or having no treatment, and what could happen with each?
• How certain is the evidence for each option, and how well does it apply to someone with my health history?
• How would each option affect my daily routine, recovery time, costs, and need for future treatment?